NexgenRx Inc. (TSXV:NXG)

NexgenRx Revenue

NexgenRx had revenue of 4.62M CAD in the quarter ending September 30, 2025, with 13.43% growth. This brings the company's revenue in the last twelve months to 17.71M, up 11.77% year-over-year. In the year 2024, NexgenRx had annual revenue of 16.48M with 18.99% growth.

• Revenue (ttm): 17.71M
• Revenue Growth: +11.77%
• P/S Ratio: 1.37
• Revenue / Employee: 885.68K
• Employees: 20
• Market Cap: 24.18M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	16.48M	2.63M	18.99%
Dec 31, 2023	13.85M	1.07M	8.33%
Dec 31, 2022	12.78M	939.94K	7.94%
Dec 31, 2021	11.84M	799.96K	7.25%
Dec 31, 2020	11.04M	1.50M	15.74%
Dec 31, 2019	9.54M	2.37M	33.06%
Dec 31, 2018	7.17M	1.50M	26.41%
Dec 31, 2017	5.67M	-83.19K	-1.45%
Dec 31, 2016	5.75M	1.06M	22.65%
Dec 31, 2015	4.69M	475.62K	11.28%
Dec 31, 2014	4.22M	-694.11K	-14.14%
Dec 31, 2013	4.91M	514.77K	11.71%
Dec 31, 2012	4.40M	442.02K	11.18%
Dec 31, 2011	3.95M	429.37K	12.18%
Dec 31, 2010	3.52M	583.43K	19.84%
Dec 31, 2009	2.94M	985.01K	50.36%
Dec 31, 2008	1.96M	1.44M	279.05%
Dec 31, 2007	516.00K	278.00K	116.81%
Dec 31, 2006	238.00K	211.00K	781.48%
Dec 31, 2005	27.00K	-	-